Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Immunosuppressants reported by DuPont Merck

July 19, 1996

American Home Products issued U.S. patent for 42-epi-rapamycin

July 19, 1996

Positive safety, efficacy profile of HMG-CoA reductase inhibitors in hyperlipidemia treatment

July 12, 1996

ICOS issued U.S. patent relating to ICAM-3

July 12, 1996

TCV-309: Potential agent for transplantation of ischemically injured kidney

July 12, 1996

GT32-B: a novel antibacterial/antitumor immunosuppresant

July 12, 1996

Sankyo reveals potential immunosupressants

July 12, 1996

Immunosuppressive and antiinflammatory agents from Italfarmaco

July 12, 1996

Dacliximab receives patent protection in U.S.

July 5, 1996

Pfizer's CJ-12798 claimed as immunosuppressant, antifungal and antitumor agent

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...